New York State Common Retirement Fund
URGN icon

New York State Common Retirement Fund’s UroGen Pharma URGN Stock Holding History

New York State Common Retirement Fund’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$579K Buy
15,737
+3,000
+24% +$81.3K ﹤0.01% 1950
2026
Q1 		$229K Hold
12,737
– – ﹤0.01% 2181
2025
Q4 		$298K Buy
12,737
+4,900
+63% +$106K ﹤0.01% 2131
2025
Q3 		$156K Hold
7,837
– – ﹤0.01% 2412
2025
Q2 		$107K Hold
7,837
– – ﹤0.01% 2546
2025
Q1 		$86.7K Hold
7,837
– – ﹤0.01% 2580
2024
Q4 		$83.5K Hold
7,837
– – ﹤0.01% 2669
2024
Q3 		$99.5K Sell
7,837
-7,000
-47% -$104K ﹤0.01% 2587
2024
Q2 		$249K Buy
14,837
+5,914
+66% +$84.1K ﹤0.01% 2334
2024
Q1 		$134K Buy
8,923
+360
+4% +$5.88K ﹤0.01% 2626
2023
Q4 		$128K Sell
8,563
-37
-0.4% -$480 ﹤0.01% 2640
2023
Q3 		$120K Buy
8,600
+200
+2% +$3.21K ﹤0.01% 2634
2023
Q2 		$86.9K Buy
+8,400
New +$92.7K ﹤0.01% 2961
2022
Q3 		– Sell
-174
Closed -$1K – 3451
2022
Q2 		$1K Sell
174
-13,400
-99% -$92K ﹤0.01% 3415
2022
Q1 		$118K Sell
13,574
-18
-0.1% -$140 ﹤0.01% 2988
2021
Q4 		$129K Sell
13,592
-1,909
-12% -$26.9K ﹤0.01% 3015
2021
Q3 		$261K Sell
15,501
-3,157
-17% -$50K ﹤0.01% 2804
2021
Q2 		$285K Sell
18,658
-242
-1% -$4.38K ﹤0.01% 2878
2021
Q1 		$368K Sell
18,900
-1,000
-5% -$21.2K ﹤0.01% 2594
2020
Q4 		$359K Hold
19,900
– – ﹤0.01% 2509
2020
Q3 		$384K Hold
19,900
– – ﹤0.01% 2344
2020
Q2 		$520K Buy
19,900
+3,600
+22% +$88K ﹤0.01% 2179
2020
Q1 		$291K Hold
16,300
– – ﹤0.01% 2279
2019
Q4 		$544K Sell
16,300
-2,900
-15% -$79.2K ﹤0.01% 2258
2019
Q3 		$458K Hold
19,200
– – ﹤0.01% 2379
2019
Q2 		$690K Buy
+19,200
New +$708K ﹤0.01% 2212

Other funds holding URGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

New York State Common Retirement Fund's URGN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its UroGen Pharma (URGN) stake by 24% in Q2 2026, buying an estimated $81.3K and bringing the position to 15,737 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

New York State Common Retirement Fund first reported a position in URGN in Q2 2019 and has held it in 26 quarters since. The position peaked at $690K in Q2 2019. 55 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • New York State Common Retirement Fund held 15,737 shares of UroGen Pharma worth $579K as of Q2 2026.
  • New York State Common Retirement Fund bought 3,000 UroGen Pharma shares in Q2 2026, an estimated $81.3K.
  • UroGen Pharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1950 holding.
  • New York State Common Retirement Fund first reported a position in UroGen Pharma in Q2 2019 and has held it in 26 quarters since.
  • New York State Common Retirement Fund's UroGen Pharma position peaked at $690K in Q2 2019.
  • 55 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.